United Therapeutics Corp. (UTHR)
591.11
-2.20
(-0.37%)
USD |
NASDAQ |
Nov 13, 16:00
591.11
0.00 (0.00%)
After-Hours: 19:32
United Therapeutics Price to Book Value : 3.992 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 4.007 |
| November 11, 2026 | 4.022 |
| November 10, 2026 | 3.975 |
| November 09, 2026 | 3.933 |
| November 06, 2026 | 3.795 |
| November 05, 2026 | 3.820 |
| November 04, 2026 | 4.109 |
| November 03, 2026 | 4.061 |
| November 02, 2026 | 4.026 |
| October 30, 2026 | 4.043 |
| October 29, 2026 | 4.008 |
| October 28, 2026 | 3.960 |
| October 27, 2026 | 3.992 |
| October 26, 2026 | 4.004 |
| October 23, 2026 | 3.967 |
| October 22, 2026 | 3.949 |
| October 21, 2026 | 3.805 |
| October 20, 2026 | 3.740 |
| October 19, 2026 | 3.668 |
| October 16, 2026 | 3.600 |
| October 15, 2026 | 3.657 |
| October 14, 2026 | 3.647 |
| October 13, 2026 | 3.670 |
| October 12, 2026 | 3.715 |
| October 09, 2026 | 3.708 |
| Date | Value |
|---|---|
| October 08, 2026 | 3.598 |
| October 07, 2026 | 3.680 |
| October 06, 2026 | 3.658 |
| October 05, 2026 | 3.622 |
| October 02, 2026 | 3.658 |
| October 01, 2026 | 3.859 |
| September 30, 2026 | 3.659 |
| September 29, 2026 | 3.210 |
| September 28, 2026 | 3.238 |
| September 25, 2026 | 3.170 |
| September 24, 2026 | 3.149 |
| September 23, 2026 | 3.263 |
| September 22, 2026 | 3.318 |
| September 21, 2026 | 3.288 |
| September 18, 2026 | 3.298 |
| September 17, 2026 | 3.316 |
| September 16, 2026 | 3.324 |
| September 15, 2026 | 3.336 |
| September 14, 2026 | 3.352 |
| September 11, 2026 | 3.315 |
| September 10, 2026 | 3.360 |
| September 09, 2026 | 3.379 |
| September 08, 2026 | 3.320 |
| September 04, 2026 | 3.251 |
| September 03, 2026 | 3.269 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Liquidia Corp. | -- |
| Alnylam Pharmaceuticals, Inc. | 6.130 |
| Exelixis, Inc. | 9.204 |
| Gilead Sciences, Inc. | 16.00 |
| Insmed, Inc. | 36.59 |
Price to Book Value Related Metrics
| PE Ratio | 22.30 |
| PS Ratio | 8.605 |
| PEG Ratio | 48.91 |
| Price to Free Cash Flow | 31.75 |
| Price | 591.11 |
| Earnings Yield | 4.48% |
| Market Cap | 25.05B |
| PEGY Ratio | 48.91 |
| Operating PE Ratio | 19.75 |
| Normalized PE Ratio | 23.23 |